| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 5 |
| 1 | AFLIBERCEPT | 4 |
| 2 | RANIBIZUMAB | 4 |
| 3 | CYCLOPHOSPHAMIDE | 3 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 3 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 3 |
| 6 | FARICIMAB | 3 |
| 7 | METHOTREXATE | 3 |
| 8 | METHOTREXATE SODIUM | 3 |
| 9 | RITUXIMAB | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRASTUZUMAB-DKST | 1 | 0.0036 |
| 1 | NIVOLUMAB AND RELATLIMAB-RMBW | 1 | 0.0019 |
| 2 | FLUOCINOLONE ACETONIDE | 2 | 0.0005 |
| 3 | FARICIMAB | 3 | 0.0003 |
| 4 | RANIBIZUMAB | 4 | 0.0002 |
| 5 | LORLATINIB | 1 | 0.0001 |
| 6 | AFLIBERCEPT | 4 | 0.0001 |
| 7 | ATOVAQUONE | 1 | 0.0001 |
| 8 | MERCAPTOPURINE | 2 | 0.0001 |
| 9 | FAM-TRASTUZUMAB DERUXTECAN-NXKI | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 1 | Antimalarial [EPC] | 1 | 0.0001 |
| 2 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 10 | 0.0001 |
| 4 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 5 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | Alkylating Drug [EPC] | 3 | 0.0000 |
| 7 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 1 | 0.0000 |
| 8 | Dietary Cholesterol Absorption Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |